歐洲細胞培養基市場規模、份額及趨勢分析報告－產業概覽及2032年預測

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Europe Cell Culture Media Market
请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

歐洲細胞培養基市場規模、份額及趨勢分析報告－產業概覽及2032年預測

  • Healthcare
  • Published Report
  • Feb 2025
  • Europe
  • 350 页面
  • 桌子數： 124
  • 图号： 33
  • Author : Sachin Pawar
立即购买 立即购买 索取樣品 索取樣品
Nucleus Nucleus

通过敏捷供应链咨询解决关税挑战

供应链生态系统分析现已成为 DBMR 报告的一部分

Europe Cell Culture Media Market

市场规模（十亿美元）

CAGR :  % Diagram

Chart Image USD 1.90 Billion USD 4.29 Billion 2024 2032
Diagram Forecast Period
 2025 –2032
Diagram Market Size (Base Year)
 USD 1.90 Billion
Diagram Market Size (Forecast Year)
 USD 4.29 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Merck KGaA
  • Sartorius AG
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Cytiva

歐洲細胞培養基市場細分，按類型（化學定義培養基、經典培養基、無血清培養基、特殊培養基、幹細胞培養基、溶源性肉湯 (LB)、客製化培養基配方等）、應用（生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、第三方分銷與研究實驗室、醫院、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、第三方分銷與研究實驗室、醫院、診斷中心、 20-2033 實驗室市場（20-20 實驗室）年）

歐洲細胞培養基市場 Z

歐洲細胞培養基市場規模

  • 2024 年歐洲細胞培養基市場規模為19 億美元 ，預計 到 2032 年將達到 42.9 億美元，預測期內 複合年增長率為 10.70%。
  • 市場成長主要得益於歐洲對生物製藥的需求不斷增長，以及學術、臨床和工業應用領域細胞研究的進步
  • 此外，再生醫學和個人化醫療保健的投資不斷增加，以及對疫苗生產和癌症研究的高度關注，使得細胞培養基成為現代生物技術工作流程的關鍵組成部分。這些因素共同推動市場擴張，並為歐洲細胞培養基產業塑造了強勁的未來。

歐洲細胞培養基市場分析

  • 細胞培養基對於支持細胞體外生長和維持至關重要，由於其在提高細胞活力、生產力和可重複性方面發揮作用，在歐洲的生物製藥製造、再生醫學和高級研究應用中越來越重要
  • 細胞培養基需求的不斷增長主要受到生物技術和製藥行業的不斷擴張、細胞療法投資的不斷增加以及需要生物製劑的慢性疾病盛行率的上升所驅動。
  • 德國在歐洲細胞培養基市場佔據主導地位，2024 年的收入份額最高，為 29.9%，這得益於其強勁的製藥業、強大的學術研究網絡以及政府對生物技術創新（特別是在腫瘤學和個性化醫療領域）的資助
  • 預計波蘭將成為預測期內歐洲細胞培養基市場成長最快的國家，這得益於研發基礎設施投資的增加、政府支持政策以及當地生物技術新創企業的成長
  • 無血清培養基在歐洲細胞培養基市場佔據主導地位，2024 年的市佔率為 40%，這得益於監管偏好、較低的污染風險以及在疫苗和單株抗體生產中的日益普及

報告範圍和歐洲細胞培養基市場細分 

屬性

歐洲細胞培養基關鍵市場洞察

涵蓋的領域
  • 依類型：化學成分培養基、經典培養基、無血清培養基、特殊培養基、幹細胞培養基、溶源性肉湯（Lb）、客製化培養基配方等
  • 依應用：生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等
  • 按最終用戶：生物製藥公司、生物技術組織、學術和研究實驗室、醫院、診斷中心、細胞庫、法醫實驗室等
  • 按分銷管道：直接投標、第三方分銷和零售

覆蓋國家

歐洲

  • 德國
  • 法國
  • 英國
  • 荷蘭
  • 瑞士
  • 比利時
  • 俄羅斯
  • 義大利
  • 西班牙
  • 火雞
  • 歐洲其他地區

主要市場參與者
  • 默克集團（德國）
  • 賽多利斯股份公司（德國）
  • 龍沙集團（瑞士）
  • 賽默飛世爾科技公司（美國）
  • Cytiva（美國）
  • PAN-Biotech GmbH（德國）
  • PromoCell GmbH（德國）
  • 康寧公司（美國）
  • HiMedia Laboratories Pvt. Ltd.（印度）
  • 富士膠片爾灣科學公司（美國）
  • Eppendorf SE（德國）
  • Bio-Techne公司（美國）
  • Repligen公司（美國）
  • STEMCELL Technologies Inc.（加拿大）
  • BD（美國）
  • Takara Bio Europe SAS（法國）
  • CellGenix GmbH（德國）
  • Miltenyi Biotec BV & Co. KG（德國）

市場機會
  • 不斷加強的合作與夥伴關係
  • 生物製藥和疫苗需求增加

加值資料資訊集

除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括深入的專家分析、定價分析、品牌份額分析、消費者調查、人口統計分析、供應鏈分析、價值鏈分析、原材料/消耗品概述、供應商選擇標準、PESTLE 分析、波特分析和監管框架。

歐洲細胞培養基市場趨勢

“轉向無血清和化學成分培養基”

  • 歐洲細胞培養基市場的一個重要且加速的趨勢是轉向無血清和化學成分確定的培養基，這種培養基具有更高的一致性、更低的污染風險和更高的法規遵從性，特別是在生物製藥生產和基於細胞的研究中
    • 例如，默克公司和賽多利斯公司推出了專為細胞治療和疫苗生產而設計的無血清培養基，有助於簡化工作流程，同時滿足嚴格的GMP標準。同樣，賽默飛世爾科技公司也持續擴展其化學成分明確的培養基產品組合，以滿足可擴展的生物生產應用。
  • 這些培養基配方不含動物性成分，符合倫理研究規範，並最大程度地降低了引入外來因子的風險，這在臨床級生產中尤其重要。此外，它們還能幫助研究人員更好地控制實驗變量，並提高在學術和工業環境中的可重複性。
  • 德國、法國和英國等國家對高品質生物製劑、幹細胞研究和精準醫療的需求不斷增長，正在加速這些先進製劑的採用
  • 這一轉變促進了單株抗體、細胞療法和重組蛋白生產過程的更有效率擴大，有助於降低下游純化需求並提高產品產量
  • 高性能、符合法規要求的培養基趨勢正在從根本上重塑實驗室實踐和製造標準，促使主要參與者創新解決方案，以支持在研究、開發和商業生產過程中保持一致的性能

歐洲細胞培養基市場動態

司機

“不斷擴大的生物製藥行業和支持性研究生態系統”

  • 歐洲對細胞培養基的需求不斷增長，這主要得益於生物製藥行業的擴張以及政府舉措和資助計劃支持的研究生態系統
    • 例如，2024 年 3 月，德國政府宣布根據國家製藥策略增加對生命科學和生物製造基礎設施的資助，旨在促進國內生物製劑和疫苗的生產
  • 隨著生物療法變得越來越普遍，特別是對於慢性病和罕見疾病，德國、英國和瑞士的主要製藥和生物技術中心對支持大規模細胞培養的高性能培養基的需求日益增加
  • 此外，「地平線歐洲」計畫下以研究為重點的舉措正在支持再生醫學和細胞治療領域的合作項目，進一步刺激學術和臨床領域對專業化、無血清且符合 GMP 標準的培養基的需求
  • 3D 細胞培養模型和類器官系統在個人化醫療中的日益普及，也推動了創新培養基解決方案的採用，這些解決方案旨在支持複雜的細胞類型和培養環境
  • 公共和私營部門在推動生物技術和細胞研究方面的利益一致，鞏固了歐洲作為細胞培養基和相關生物加工解決方案領先市場的地位

克制/挑戰

“產品成本高，監管環境複雜”

  • 專用細胞培養基（尤其是化學成分確定和 GMP 級配方）成本高昂，對於歐洲小型研究機構和新興生物技術公司廣泛採用仍然是一個重大挑戰
    • 例如，雖然龍沙和賽默飛世爾科技等領先製造商提供針對細胞治療和疫苗生產優化的先進培養基，但這些產品的高昂定價可能會限制預算有限的用戶的使用。
  • 此外，歐洲藥品管理局 (EMA) 和國家衛生當局製定的嚴格監管要求，要求對臨床和商業應用中使用的任何培養基進行廣泛的記錄、品質保證和驗證流程，這增加了供應商和用戶的營運負擔，例如
  • 要遵守這些法規，需要投資於經過認證的製造設施、詳細的組件可追溯性以及持續的品質審核，這可能會延長產品開發時間並增加成本
  • 此外，歐盟各國監管預期的差異可能會為尋求大規模商業化或分銷細胞培養產品的公司帶來額外的障礙
  • 透過具有成本效益的創新、協調監管框架以及增加對早期研究的資金支持來應對這些挑戰，對於釋放歐洲細胞培養基市場的全部成長潛力至關重要

歐洲細胞培養基市場範圍

市場根據類型、應用、最終用戶和分銷管道進行細分。

  • 按類型

歐洲細胞培養基市場按類型細分為化學成分確定的培養基、經典培養基、無血清培養基、特殊培養基、幹細胞培養基、溶源性肉湯 (LB)、客製化培養基配方等。無血清培養基佔據市場主導地位，2024 年市場收入份額最高，達到 40%，這得益於其污染風險更低、批次一致性更高，以及生物製藥和疫苗生產中監管部門更傾向於使用無動物成分。隨著歐洲製藥公司越來越注重開發更安全、更標準化的治療產品，對無血清製劑的需求也日益增長。

預計化學成分確定培養基領域將在2025年至2032年間實現最快的增長，這得益於其在精準細胞培養應用中的廣泛應用，以及其符合GMP認證生產設施的嚴格品質要求。由於其可重複性、成分可控以及能夠滿足不斷變化的監管標準，此類培養基在幹細胞治療、診斷和細胞檢測領域正日益受到青睞。

  • 按應用

根據應用，歐洲細胞培養基市場細分為生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等。生物製藥生產領域在2024年佔據了最大的市場份額，這得益於該地區強大的生物製劑產品線以及對哺乳動物細胞培養在治療性蛋白質和單株抗體生產中的日益依賴。德國、瑞士和英國的領先製藥公司正在大力投資可擴展、高產量的培養基解決方案，以優化其生產流程。

再生醫學和組織工程領域預計將在預測期內以最快的速度成長，這得益於幹細胞研究的進步以及細胞和基因治療臨床試驗資金的增加。對支持多能細胞生長和分化的專用培養基的需求，為該領域的市場擴張創造了新的機會。

  • 按最終用戶

根據最終用戶，歐洲細胞培養基市場細分為生物製藥公司、生物技術機構、學術和研究實驗室、醫院、診斷中心、細胞庫、法醫實驗室等。生物製藥公司在2024年佔據了最大的市場收入份額，這歸因於其在藥物開發和商業生產中大規模使用細胞培養基。歐洲生物製劑需求的不斷增長以及主要行業參與者的存在推動了該細分市場的主導地位。

預計學術和研究實驗室將在 2025 年至 2032 年間經歷最快的增長，這得益於歐盟和國家對生物醫學研究的資助不斷增加，以及學術機構和生物技術公司之間在基於細胞的創新和疾病建模方面的合作日益加強。

  • 按分銷管道

根據分銷管道，歐洲細胞培養基市場分為直接招標、第三方分銷和零售。由於醫院、研究機構和製藥商的大量採購，直接招標在2024年佔據市場主導地位，這些採購通常與培養基供應商簽訂長期合約。這些安排提供更優惠的價格，確保持續供應，並符合採購法規，尤其是在公共和機構環境中。

預計第三方分銷領域將在預測期內實現最高成長率，這得益於專業生命科學分銷商的不斷增加，以及對精簡物流和庫存管理服務的需求不斷增長。生技新創公司和小型研究實驗室尋求靈活採購方案的興起，進一步支持了此類分銷模式的擴張。

歐洲細胞培養基市場區域分析

  • 德國在歐洲細胞培養基市場佔據主導地位，2024 年的收入份額最高，為 29.9%，這得益於其強勁的製藥業、強大的學術研究網絡以及政府對生物技術創新（特別是在腫瘤學和個性化醫療領域）的資助
  • 該國已成為生物製劑生產和細胞研究的中心，各機構和公司優先考慮用於藥物開發、疫苗生產和先進治療應用的高品質培養基
  • 德國致力於創新，擁有完善的監管框架，並積極開展學術機構和行業參與者之間的合作，進一步鞏固了其領導地位，使其成為研究和商業領域培養基供應商的關鍵市場。

德國細胞培養基市場洞察

2024年，德國細胞培養基市場佔歐洲最大收入份額，這得益於其強大的製藥製造基礎和政府支持的生物技術創新措施。大型製藥公司和學術機構積極參與細胞療法和疫苗研究，推動了對無血清和化學成分確定培養基的需求。德國遵守嚴格的監管框架並致力於科學進步，這進一步鞏固了其在歐洲市場的領先地位。

英國細胞培養基市場洞察

英國細胞培養基市場預計將穩定成長，這得益於其領先的學術機構、強大的生物製藥產業以及對細胞創新的重視。基因和細胞療法研究是關鍵的成長動力，越來越多的機構採用成分確定型和無血清培養基來提高可重複性。全球供應商的存在以及對下一代生物製造技術的關注，進一步提升了英國在市場中的地位。

波蘭細胞培養基市場洞察

預計波蘭細胞培養基市場在預測期內將實現強勁的複合年增長率，這得益於政府加強對生物技術發展的支持力度以及研究基礎設施的擴建。波蘭正逐漸成為中東歐地區臨床試驗和生物製藥生產的重要樞紐，從而推動對高品質、價格實惠的培養基的需求不斷增長。研發中心的投資、與歐洲學術機構的合作以及國際供應商的日益壯大，正在推動波蘭在歐洲細胞培養基領域的地位不斷提升。

歐洲細胞培養基市場份額

歐洲細胞培養基產業主要由知名公司主導，包括：

  • 默克集團（德國）
  • 賽多利斯股份公司（德國）
  • 龍沙集團（瑞士）
  • 賽默飛世爾科技公司（美國）
  • Cytiva（美國）
  • PAN-Biotech GmbH（德國）
  • PromoCell GmbH（德國）
  • 康寧公司（美國）
  • HiMedia Laboratories Pvt. Ltd.（印度）
  • 富士膠片爾灣科學公司（美國）
  • Eppendorf SE（德國）
  • Bio-Techne公司（美國）
  • Repligen公司（美國）
  • STEMCELL Technologies Inc.（加拿大）
  • BD（美國）
  • Takara Bio Europe SAS（法國）
  • CellGenix GmbH（德國）
  • Miltenyi Biotec BV & Co. KG（德國）

歐洲細胞培養基市場的最新發展是什麼？

  • 2024年4月，德國默克集團（Merck KGaA）擴建了位於達姆施塔特的細胞培養基生產設施，以滿足該地區對用於生物製劑和疫苗生產的高品質、符合GMP標準的培養基日益增長的需求。此次擴建體現了默克致力於增強歐洲生物製藥供應鏈韌性的決心，以及其作為歐洲大陸先進療法製造商關鍵供應商的地位。
  • 2024年3月，德國賽多利斯公司宣布推出專為幹細胞和CAR-T細胞應用量身訂製的全新化學成分限定培養基產品組合。該產品系列由公司與領先的學術合作夥伴合作開發，支持下一代療法的可擴展生產，並增強細胞療法生產工作流程的可重複性和合規性。
  • 2024年2月，瑞士龍沙集團在菲斯普開設了一個新的研發中心，專注於免疫療法和再生醫學專用培養基配方的創新。這項策略性舉措旨在加速參與尖端細胞研究和先進生物製劑生產的歐洲客戶的產品開發。
  • 2024年2月，賽默飛世爾科技（業務遍及歐洲）與牛津大學合作，共同開發用於神經科學和類器官研究的客製化培養基。該計劃透過提供針對性的配方來支持學術研究，以提高細胞活力和實驗一致性，從而加強公司在該地區強大的產學研聯繫。
  • 2024年1月，PAN-Biotech GmbH（德國）推出了專為間質幹細胞擴增而設計的全新GMP級無血清培養基。此次發布旨在支持細胞療法的臨床級生產，並反映出歐洲對滿足研究和監管需求的無異源可擴展培養基解決方案的需求日益增長。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE CELL CULTURE MEDIA MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

5 EUROPE CELL CULTURE MEDIA MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE

6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE

6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS

6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT

6.2 RESTRAINTS

6.2.1 RISKS ASSOCIATED WITH CONTAMINATION

6.2.2 HIGH COST OF PRODUCTION

6.3 OPPORTUNITIES

6.3.1 RISING COLLABORATION AND PARTNERSHIPS

6.3.2 INCREASING DEMAND FOR BIOPHARMACEUTICALS AND VACCINES

6.3.3 INNOVATIONS IN 3D CELL CULTURE

6.4 CHALLENGES

6.4.1 COMPLEXITY OF MEDIA FORMULATION

6.4.2 INTENSE MARKET COMPETITION

7 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE

7.1 OVERVIEW

7.2 CHEMICALLY DEFINED MEDIA CHEMICALLY DEFINED MEDIA

7.3 CLASSICAL MEDIA

7.4 SERUM-FREE MEDIA

7.5 SPECIALTY MEDIA

7.6 STEM CELL MEDIA

7.7 LYSOGENY BROTH (LB)

7.8 CUSTOM MEDIA FORMULATION

7.9 OTHERS

8 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 BIOPHARMACEUTICAL PRODUCTION

8.3 DRUG SCREENING & DEVELOPMENT

8.4 DIAGNOSTICS

8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING

8.6 OTHERS

9 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER

9.1 OVERVIEW

9.2 BIOPHARMACEUTICAL COMPANIES

9.3 BIOTECHNOLOGY ORGANIZATIONS

9.4 ACADEMIC AND RESEARCH LABORATORIES

9.5 HOSPITALS

9.6 DIAGNOSTIC CENTERS

9.7 CELL BANKS

9.8 FORENSIC LABORATORIES

9.9 OTHERS

10 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDERS

10.3 THIRD PARTY DISTRIBUTION

10.4 RETAILS SALES

11 EUROPE CELL CULTURE MEDIA MARKET, BY REGION

11.1 EUROPE

11.1.1 GERMANY

11.1.2 U.K.

11.1.3 FRANCE

11.1.4 NETHERLANDS

11.1.5 SPAIN

11.1.6 SWITZERLAND

11.1.7 BELGIUM

11.1.8 ITALY

11.1.9 RUSSIA

11.1.10 TURKEY

11.1.11 REST OF EUROPE

12 EUROPE CELL CULTURE MEDIA MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 MERCK KGAA

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 DANAHER CORPORATION (CYTIVA)

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 SARTORIUS AG

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 LONZA

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENT

14.6 CORNING INCORPORATED

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 COMPANY SHARE ANALYSIS

14.6.4 PRODUCT PORTFOLIO

14.6.5 RECENT UPDATES

14.7 AJINOMOTO CO., INC

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 AKRON BIOTECH

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 BD

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT UPDATES

14.1 BIO-RAD LABORATORIES, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 REVENUE ANALYSIS

14.10.3 PRODUCT PORTFOLIO

14.10.4 RECENT DEVELOPMENT

14.11 CAISSON LABS INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT UPDATES

14.12 CELL APPLICATION, INC.

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT UPDATES

14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 FUJIFILM HOLDINGS CORPORATION

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT UPDATES

14.15 HIMEDIA LABORATORIES

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT UPDATES

14.16 KOH JIN-BIO CO., LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT UPDATES

14.17 PAN-BIOTECH

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT UPDATES

14.18 PROMOCELL GMBH

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT UPDATES

14.19 SERA-SCANDIA A/S

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 STEMCELL TECHNOLOGIES

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 TAKARA BIO INC.

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

表格列表

TABLE 1 GMP REQUIREMENTS

TABLE 2 SCOPE OF THE CURRENT DOCUMENT

TABLE 3 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 4 EUROPE CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 5 EUROPE CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 6 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 7 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 8 EUROPE SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 9 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 10 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 11 EUROPE LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 12 EUROPE CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 13 EUROPE OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 14 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 15 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 16 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 17 EUROPE DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 18 EUROPE DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 19 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 20 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 21 EUROPE OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 22 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 23 EUROPE BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 24 EUROPE BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 25 EUROPE ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 26 EUROPE HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 27 EUROPE DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 28 EUROPE CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 29 EUROPE FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 30 EUROPE OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 31 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 32 EUROPE DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 33 EUROPE THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 34 EUROPE RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 35 EUROPE CELL CULTURE MEDIA MARKET, BY COUNTRY, 2018-2035 (USD MILLION)

TABLE 36 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 37 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 38 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 39 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 40 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 41 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 42 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 43 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 44 GERMANY CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 45 GERMANY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 46 GERMANY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 47 GERMANY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 48 GERMANY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 49 GERMANY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 50 GERMANY CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 51 GERMANY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 52 U.K. CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 53 U.K. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 54 U.K. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 55 U.K. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 56 U.K. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 57 U.K. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 58 U.K. CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 59 U.K. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 60 FRANCE CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 61 FRANCE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 62 FRANCE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 63 FRANCE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 64 FRANCE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 65 FRANCE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 66 FRANCE CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 67 FRANCE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 68 NETHERLANDS CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 69 NETHERLANDS SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 70 NETHERLANDS STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 71 NETHERLANDS CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 72 NETHERLANDS BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 73 NETHERLANDS REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 74 NETHERLANDS CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 75 NETHERLANDS CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 76 SPAIN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 77 SPAIN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 78 SPAIN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 79 SPAIN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 80 SPAIN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 81 SPAIN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 82 SPAIN CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 83 SPAIN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 84 SWITZERLAND CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 85 SWITZERLAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 86 SWITZERLAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 87 SWITZERLAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 88 SWITZERLAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 89 SWITZERLAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 90 SWITZERLAND CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 91 SWITZERLAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 92 BELGIUM CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 93 BELGIUM SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 94 BELGIUM STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 95 BELGIUM CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 96 BELGIUM BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 97 BELGIUM REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 98 BELGIUM CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 99 BELGIUM CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 100 ITALY CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 101 ITALY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 102 ITALY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 103 ITALY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 104 ITALY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 105 ITALY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 106 ITALY CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 107 ITALY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 108 RUSSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 109 RUSSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 110 RUSSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 111 RUSSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 112 RUSSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 113 RUSSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 114 RUSSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 115 RUSSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 116 TURKEY CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 117 TURKEY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 118 TURKEY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 119 TURKEY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 120 TURKEY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 121 TURKEY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 122 TURKEY CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 123 TURKEY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 124 REST OF EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

图片列表

FIGURE 1 EUROPE CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 2 EUROPE CELL CULTURE MEDIA MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE CELL CULTURE MEDIA MARKET: DROC ANALYSIS

FIGURE 4 EUROPE CELL CULTURE MEDIA MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 EUROPE CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 11 EXECUTIVE SUMMARY

FIGURE 12 STRATEGIC DECISIONS BY KEY PLAYERS

FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE EUROPE CELL CULTURE MEDIA MARKET FROM 2025 TO 2035

FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CELL CULTURE MEDIA MARKET IN 2025 AND 2035

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE CELL CULTURE MEDIA MARKET

FIGURE 16 EUROPE CELL CULTURE MEDIA MARKET: BY TYPE, 2024

FIGURE 17 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2025-2035

FIGURE 18 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, CAGR, 2025-2035

FIGURE 19 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, LIFE LINE CURVE

FIGURE 20 EUROPE CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024

FIGURE 21 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION,2025-2035

FIGURE 22 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, CAGR (2025-2035)

FIGURE 23 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, LIFE LINE CURVE

FIGURE 24 EUROPE CELL CULTURE MEDIA MARKET: BY END-USER, 2024

FIGURE 25 EUROPE CELL CULTURE MEDIA MARKET, BY END USER, (2025-2035)

FIGURE 26 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, CAGR (2025-2035)

FIGURE 27 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, LIFE LINE CURVE

FIGURE 28 EUROPE CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 29 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL,2025-2035

FIGURE 30 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, CAGR, (2025-2035)

FIGURE 31 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, LIFE LINE CURVE

FIGURE 32 EUROPE CELL CULTURE MEDIA MARKET: SNAPSHOT (2024)

FIGURE 33 EUROPE CELL CULTURE MEDIA MARKET: COMPANY SHARE 2024 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

市场是基于 歐洲細胞培養基市場細分，按類型（化學定義培養基、經典培養基、無血清培養基、特殊培養基、幹細胞培養基、溶源性肉湯 (LB)、客製化培養基配方等）、應用（生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、第三方分銷與研究實驗室、醫院、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、第三方分銷與研究實驗室、醫院、診斷中心、 20-2033 實驗室市場（20-20 實驗室）年） 进行细分的。
在2024年，歐洲細胞培養基市場的规模估计为1.90 USD Billion美元。
歐洲細胞培養基市場预计将在2025年至2032年的预测期内以CAGR 10.7%的速度增长。
市场上的主要参与者包括Merck KGaA , Sartorius AG, Lonza Group AG, Thermo Fisher Scientific Inc., Cytiva 。

浏览相关页面

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future